Targeted metabolomic profiling of multiple myeloma: diagnostics and treatment efficacy

Introduction. Multiple myeloma (MM) is a malignant disease of plasma cells characterized by marked heterogeneity of the clinical course and variability in response to treatment. Metabolomic analysis, which reflects the totality of small molecules in biological fluids, opens up new possibilities for...

ver descrição completa

Detalhes bibliográficos

Principais autores:	V. G. Varzieva, K. M. Shestakova, A. A. Boldin, D. A. Kutsakina, Yu. Yu. Kirichenko, Yu. N. Belenkov, I. S. Ilgisonis, V. V. Tarasov, S. A. Appolonova
Formato:	Artigo
Idioma:	Russo
Publicado em:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2025-12-01
coleção:	Разработка и регистрация лекарственных средств
Assuntos:	метаболомика множественная миелома биомаркер эффективность лечения прогноз диагностика
Acesso em linha:	https://www.pharmjournal.ru/jour/article/view/2222
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!